A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia
- 18 September 1990
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (8) , B22-B30
- https://doi.org/10.1016/0002-9149(90)90437-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Beyond CholesterolNew England Journal of Medicine, 1989
- Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.Circulation, 1989
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profilesAtherosclerosis, 1988
- A Multicenter Comparison of Lovastatin and Cholestyramine Therapy for Severe Primary HypercholesterolemiaPublished by American Medical Association (AMA) ,1988
- Probucol with Colestipol in the Treatment of HypercholesterolemiaAnnals of Internal Medicine, 1984
- Summary estimates of cholesterol used to predict coronary heart disease.Circulation, 1983
- Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemiaMetabolism, 1980
- Combining independent one-sample tests of significanceAnnals of the Institute of Statistical Mathematics, 1967